Significance of Tyrosine Kinase Inhibitors in the Treatment of Metastatic Breast Cancer

Preclinical and clinical trials suggest that tyrosine kinase inhibitors (TKI) could supplement current therapies in metastatic breast cancer (MBC). HER-2 inhibition is still a main focus. Numerous agents targeting the epidermal growth factor receptors EGFR and HER-2 are currently tested after previo...

Full description

Saved in:
Bibliographic Details
Main Authors: Mundhenke, Christoph, Strauss, Alexander, Schem, Christian
Format: Artigo
Language:Inglês
Published: S. Karger GmbH 2009
Subjects:
Review Article · Übersichtsarbeit
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC2942000/
https://ncbi.nlm.nih.gov/pubmed/20877672
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000261705
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items